Evaluation of the immunomodulatory activities of royal jelly components in vitro

Immunopharmacology and Immunotoxicology

Volumn 29, Issue 3-4, 2007, Pages 521-536

  Gasic, Sonja ^a   Vucevic, Dragana ^a   Vasilijic, Sasa ^a   Antunovic, Mirjana ^c   Chinou, Ioanna ^b   Colic, Miodrag ^a,d  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF ATHENS   (Greece)

^c MMA   (Serbia)

^d UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

IL 2 Production; NO Production; Proliferation; Royal Jelly; T Cells

Indexed keywords

3,10 DIHYDROXYDECANOIC ACID; CONCANAVALIN A; DECANOIC ACID DERIVATIVE; INTERLEUKIN 2; MEL 121; MEL 138; MEL 147; MEL 172; MEL 174; MEL 233; MEL 247; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; ROYAL JELLY; TRANS 10 HYDROXYDEC 2 ENOIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRY POWDER; ENZYME SYNTHESIS; EVALUATION; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CONCANAVALIN A; FATTY ACIDS; IMMUNOLOGIC FACTORS; INTERLEUKIN-2; MALE; METHANOL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; SOLVENTS; SPLEEN; T-LYMPHOCYTES;

RATTUS;

EID: 37149029109     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970701690977     Document Type: Article

References (36)

1. Bloodworth, B.C.; Harn, C.S.; Hock, C.T.; Boon, Y.O. Liquid chromatographic determination of trans-10-hydroxy-2-decenoic acid content of commercial products containing royal jelly. J. AOAC. Int. 1995, 78 (4), 1019-1023.
2. Karaali, A.; Meydanoglu, F.; Eke, D. Studies on composition freeze-drying and storage of turkish royal jelly. J. Apic. Res. 1988, 27, 182-185.
3. Patel, N.G.; Haydak, M.; Gochnauer, T.A. Electroporetic components of the proteins in honey bee larval food. Nature 1960, 186, 633-634.
4. Lercker, G.; Capella, P.; Conte, L.S.; Ruini, F.; Giordani, G. Components of royal jelly : I. Identification of the organic acids. Lipids 1981, 12, 912-919.
5. Plettner, E.; Slessor, K.N.; Winston, M.L. Biosynthesis of mandibular acids in honeybees (apis mellifera): de novo synthesis, route of fatty acid hydroxylation and caste selective β-oxidation. Insect Biochem. Mol. Biol. 1998, 28, 31-42.
6. Shinoda, M.; Nakajin, S.; Oikawa, T.; Sato, K.; Kamogawa, A.; Akiyama, Y. [Biochemical studies on vasodilative factor in royal jelly (author's transl)]. Yakugaku Zasshi 1978, 98 (2), 139-145.
7. Vittek, J. Effect of royal jelly on serum lipids in experimental animals and humans with atherosclerosis. Experientia 1995, 51 (9-10), 927-935.
8. Bincoletto, C.; Eberlin, S.; Figueiredo, C.A.; Luengo, M.B.; Queiroz, M.L. Effects produced by Royal Jelly on haematopoiesis: relation with host resistance against Ehrlich ascites tumour challenge. Int. Immunopharmacol. 2005, 5 (4), 679-688.
9. Fontana, R.; Mendes, M.A.; de Souza, B.M.; Konno, K.; Cesar, L.M.; Malaspina, O.; Palma, M.S. Jelleines: a family of antimicrobial peptides from the Royal Jelly of honeybees (Apis mellifera). Peptides 2004, 25 (6), 919-928.
10. Fujiwara, S.; Imai, J.; Fujiwara, M.; Yaeshima, T.; Kawashima, T.; Kobayashi, K. A potent antibacterial protein in royal jelly. Purification and determination of the primary structure of royalisin. J. Biol. Chem. 1990, 265 (19), 11333-11337.
11. Klaudiny, J.; Albert, S.; Bachanova, K.; Kopernicky, J.; Simuth, J. Two structurally different defensin genes, one of them encoding a novel defensin isoform, are expressed in honeybee Apis mellifera. Insect. Biochem. Mol. Biol. 2005, 35 (1), 11-22.
12. Okamoto, I.; Taniguchi, Y.; Kunikata, T.; Kohno, K.; Iwaki, K.; Ikeda, M.; Kurimoto, M. Major royal jelly protein 3 modulates immune responses in vitro and in vivo. Life Sci. 2003, 73 (16), 2029-2045.
13. Kohno, K.; Okamoto, I.; Sano, O.; Arai, N.; Iwaki, K.; Ikeda, M.; Kurimoto, M. Royal jelly inhibits the production of proinflammatory cytokines by activated macrophages. Biosci. Biotechnol. Biochem. 2004, 68 (1), 138-145.
14. Sver, L.; Orsolic, N.; Tadic, Z.; Njari, B.; Valpotic, I.; Basic, I. A royal jelly as a new potential immunomodulator in rats and mice. Comp. Immunol. Microbiol. Infect. Dis. 1996, 19 (1), 31-38.
15. Nagai, T.; Inoue, R.; Suzuki, N.; Nagashima, T. Antioxidant properties of enzymatic hydrolysates from royal jelly. J. Med. Food. 2006, 9 (3), 363-367.
16. Salazar-Olivo, L.A.; Paz-Gonzalez, V. Screening of biological activities present in honeybee (Apis mellifera) royal jelly. Toxicol. In Vitro. 2005, 19 (5), 645-651.
17. Liu, L.S.; Xiao, X.N.; Zheng, R.C. Therapeutic effect of royal jelly on radiation injury in mice and its possible mechanism. Chung Hua Fang She I Hsueh Yu Fang Hu Tsa Chih. 1984, 4, 25-26.
18. Majtan, J.; Kovacova, E.; Bilikova, K.; Simuth, J. The immunostimulatory effect of the recombinant apalbumin 1-major honeybee royal jelly protein-on TNFalpha release. Int. Immunopharmacol. 2006, 6 (2), 269-278.
19. Townsend, G.F.; Brown, W.H.; Felauer, E.E.; Hazlett, B. Studies on the in vitro antitumor activity of fatty acids. IV. The esters of acids closely related to 10-hydroxy-2-decenoic acids from royal jelly against transplantable mouse leukemia. Can. J. Biochem. Physiol. 1961, 39, 1765-1770.
20. Melliou, E.; Chinou, I. Chemistry and bioactivity of royal jelly from Greece. J. Agric. Food Chem. 2005, 53 (23), 8987-8992.
21. Ding, A.H.; Nathan, C.F.; Stuehr, D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 1988, 141 (7), 2407-2412.
22. Nicoletti, I.; Migliorati, G.; Pagliacci, M. C.; Grignani, F.; Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 1991, 139 (2), 271-279.
23. Colic, M.; Gasic, S.; Vucevic, D.; Pavicic, L.; Popovic, P.; Jandric, D.; Medic-Mijacevic, L.; Rakic, L. Modulatory effect of 7-thia-8-oxoguanosine on proliferation of rat thymocytes in vitro stimulated with concanavalin A. Int. J. Immunopharmacol. 2000, 22 (3), 203-212.
24. Cupic, V.; Colic, M.; Pavicic, L.; Vucevic, D.; Varagic, V.M. Immunomodulatory effect of xylazine, an alpha(2) adrenergic agonist, on rat spleen cells in culture. J. Neuroimmunol. 2001, 113 (1), 19-29.
25. Colic, M.; Vucevic, D.; Vasilijic, S.; Popovic, L.; Pejanovic, V.; Jandric, D.; Medic-Mijacevic, L.; Rakic, L. Proliferation of spleen cells in culture stimulated by 7-thia-8-oxoguanosine: evidence that both B- and T-cells are the targets of its action. Methods Find. Exp. Clin. Pharmacol. 1999, 21 (9), 583-590.
26. Stosic-Grujicic, S.; Simic, M.M. Modulation of interleukin 1 production by activated macrophages: in vitro action of hydrocortisone, colchicine, and cytochalasin B. Cell. Immunol. 1982, 69 (2), 235-247.
27. th ed. W.B. Saunders Company, 2003.
28. Simuth, J.; Bilikova, K.; Kovacova, E.; Kuzmova, Z.; Schroder, W. Immunochemical approach to detection of adulteration in honey: physiologically active royal jelly protein stimulating TNF-alpha release is a regular component of honey. J. Agric. Food Chem. 2004, 52 (8), 2154-2158.
29. Kimura, M.; Kimura, Y.; Tsumura, K.; Okihara, K.; Sugimoto, H.; Yamada, H.; Yonekura, M. 350-kDa royal jelly glycoprotein (apisin), which stimulates proliferation of human monocytes, bears the beta1-3galactosylated N-glycan: analysis of the N-glycosylation site. Biosci. Biotechnol. Biochem. 2003, 67 (9), 2055-2058.
30. Taniguchi, Y.; Kohno, K.; Inoue, S.; Koya-Miyata, S.; Okamoto, I.; Arai, N.; Iwaki, K.; Ikeda, M.; Kurimoto, M. Oral administration of royal jelly inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice. Int. Immunopharmacol. 2003, 3 (9), 1313-1324.
31. Krenger, W.; Falzarano, G.; Delmonte, J., Jr.; Snyder, K.M.; Byon, J.C.; Ferrara, J.L. Interferon-gamma suppresses T-cell proliferation to mitogen via the nitric oxide pathway during experimental acute graft-versus-host disease. Blood 1996, 88 (3), 1113-1121.
32. Orucevic, A.; Lala, P.K. Effects of N(G)-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on IL-2-induced LAK cell generation in vivo and in vitro in healthy and tumor-bearing mice. Cell. Immunol. 1996, 169 (1), 125-132.
33. Koya-Miyata, S.; Okamoto, I.; Ushio, S.; Iwaki, K.; Ikeda, M.; Kurimoto, M. Identification of a collagen production-promoting factor from an extract of royal jelly and its possible mechanism. Biosci. Biotechnol. Biochem. 2004, 68 (4), 767-773.
34. Wahl, S.M.; Swisher, J.; McCartney-Francis, N.; Chen, W. TGF-β: the perpetrator of immune suppression by regulatory T cells and suicidal T cells. J. Leukoc. Biol. 2004, 76 (1), 15-24.
35. Pollet, S.; Bottex-Gauthier, C.; Li, M.; Potier, P.; Favier, A.; Vidal, D. Insight into some of the signaling pathways triggered by a lipid immunomodulator. Immunopharmacol. Immunotoxicol. 2002, 24 (4), 527-546.
36. Li, Q.; Verma, I.M. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2002, 2 (10), 725-734.